全文获取类型
收费全文 | 692篇 |
免费 | 56篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 36篇 |
妇产科学 | 19篇 |
基础医学 | 97篇 |
口腔科学 | 53篇 |
临床医学 | 75篇 |
内科学 | 164篇 |
皮肤病学 | 21篇 |
神经病学 | 21篇 |
特种医学 | 18篇 |
外国民族医学 | 1篇 |
外科学 | 57篇 |
综合类 | 25篇 |
预防医学 | 30篇 |
眼科学 | 7篇 |
药学 | 73篇 |
中国医学 | 1篇 |
肿瘤学 | 60篇 |
出版年
2024年 | 3篇 |
2023年 | 13篇 |
2022年 | 45篇 |
2021年 | 48篇 |
2020年 | 35篇 |
2019年 | 34篇 |
2018年 | 49篇 |
2017年 | 31篇 |
2016年 | 28篇 |
2015年 | 33篇 |
2014年 | 36篇 |
2013年 | 63篇 |
2012年 | 70篇 |
2011年 | 72篇 |
2010年 | 37篇 |
2009年 | 24篇 |
2008年 | 30篇 |
2007年 | 24篇 |
2006年 | 28篇 |
2005年 | 19篇 |
2004年 | 15篇 |
2003年 | 11篇 |
2002年 | 11篇 |
2001年 | 1篇 |
1999年 | 1篇 |
1996年 | 1篇 |
排序方式: 共有762条查询结果,搜索用时 15 毫秒
1.
2.
Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival 总被引:1,自引:0,他引:1
The etiological role of human papillomavirus (HPV) in esophageal carcinoma (EC) in relation to p53, mdm2, p21(waf), c-erbB2 and the overall survival (OS) rate was investigated. Tumor and normal tissues from 50 EC were evaluated by polymerase chain reaction and InnoLiPA for HPV. Single strand conformation polymorphism/sequencing were used to detect p53 gene mutations. Immunohistochemistry was performed to determine p53, mdm2, p21(waf)and c-erbB2 expression. Human papillomavirus was detected in 54% of tumors and in 24% of normal tissues. p53, mdm2 and c-erbB2 overexpression was detected in 68%, 70% and 60% of tumors and in 14%, 16% and 10% of normal samples, whereas loss of p21(waf) was evident in 64% of tumors. p53 mutations were detected in 20% of cases. Exon 8 and 5 showed the highest mutation rate (40% each), followed by exons 6 and 7 (10% each). There was a significant correlation between HPV and p53, mdm2, c-erbB2 overexpression. The OS was significantly associated with overexpression of p53 and loss of p21(waf). Human papillomavirus infection is frequent in Egyptian EC. Both p53-dependent and p53-independent pathways seem to be involved in HPV-associated EC. mdm2 and c-erbB2 are possible targets for HPV in the p53-independent pathway. However, only advanced stage and aberrant expression of p53 and p21(waf) are independent prognostic markers. 相似文献
3.
Ameyaw MM Tayeb M Thornton N Folayan G Tariq M Mobarek A Evans DA Ofori-Adjei D McLead HL 《Journal of human genetics》2002,47(4):172-175
HER-2, a protooncogene located on chromosome 17q21, encodes a transmembrane glycoprotein (p185) with tyrosine kinase activity.
Alterations of the HER-2 gene have been implicated in the carcinogenesis and prognosis of breast cancer and other solid tumors. It is also a cancer-therapeutic
target for antibody-based therapy against the HER-2 protein. A single-nucleotide polymorphism (SNP) at codon 655, resulting in a G-to-A transition (Ile655Val) in the transmembrane
domain-coding region of this gene has been associated with an increased risk of breast cancer, particularly among younger
women. To understand the importance of this finding throughout the world, we evaluated this polymorphism in Ghanaian, Kenyan,
Sudanese, Caucasian, African–American, Saudi, and Filipino subjects using a polymerase chain reaction-restriction fragment
length polymorphism assay. The frequency of the Val allele, which is associated with increased breast cancer risk, was highly
variable between populations (0%–24%). Continental African populations had a lower frequency of the Val allele than did Saudi,
Chinese, Filipino, Caucasian, and African–American subjects. The data suggest that this SNP has variable frequency in different
ethnic groups. The findings in this study correspond with the lower incidence and lower risk of breast cancer in African women
compared with Caucasian and African–American women.
Received: December 13, 2001 / Accepted: January 16, 2002 相似文献
4.
5.
6.
Abeer M Shaaban Valerie Speirs 《Clinical cancer research》2005,11(22):8222; author reply 8222-8222; author reply 8223
7.
Maximum androgen blockade (MAB), consisting of an antiandrogen plus either a luteinizing hormone- releasing hormone agonist (LHRHA) or orchiectomy, is a standard care for patients with prostate cancer. Although, clinical trial results have been equivocal, none has shown a significant advantage in favor of MAB over castration alone in metastatic prostate cancer and MAB has been the subject of considerable controversy. The aim of this study was to compare MAB (orchiectomy or LHRHA"Goserelin") and anti-androgen "Bicalutamide" with castration alone (orchiectomy or LHRHA) in previ- ously untreated metastatic prostate cancer patients. Methods: Hundred eligible patients with adequate performance status and adequate hematologic, hepatic and renal functions were included. MAB arm, fifty patients underwent castration either surgically by orchiectomy or medically by receiving Goserelin (3.6 rag) depot, which was injected subcutaneously every 28 days plus bicalutamide 50 mg once daily. Castration alone arm, fifty patients underwent castration alone either surgically by orchiectomy or medically by receiving Goserelin (3.6 mg) depot. Results: During the period from January 2011 to January 2013, with a median follow up of 18 months (range 6 to 24 months), there were eight deaths (16%), in MAB arm and ten deaths (20%) in castration alone arm. At three months, there were 35 patients (70%) with prostate specific antigen (PSA) normalization (-〈 4 mg/dL) in MAB arm versus 17 patients (34%) with PSA normalization in castration alone arm (P = 0.001). The median progression free survival (PFS) times were 22.18 months (95% CI, 19.7 to 24.2 months) for MAB arm versus 22 months in castration alone arm (95% CI, 18 to 25.9 months; P = 0.045). The survival rates for MAB arm were 82% at 18 months and 70.6% at 24 months versus 78.7% at 18 months and 75.1% at 24 months in castration alone arm (P 〉 0.05). The median overall survival (OS) was not reached i 相似文献
8.
Abeer S. Altowyan Mohamed Shaban Zeinab M. Faidey Khaled Abdelkarem Mawaheb Al-Dossari N. S. Abd El-Gawaad Mohamed G. M. Kordy 《Materials》2022,15(18)
In this work, a low-cost, high-yield hydrothermal treatment was used to produce nanozeolite (Zeo), nanoserpentine (Serp), and Zeo/Serp nanocomposites with weight ratios of 1:1 and 2:1. At 250 °C for six hours, the hydrothermal treatment was conducted. Various methods are used to explore the morphologies, structures, compositions, and optical characteristics of the generated nanostructures. The morphological study revealed structures made of nanofibers, nanorods, and hybrid nanofibril/nanorods. The structural study showed clinoptilolite monoclinic zeolite and antigorite monoclinic serpentine with traces of talcum mineral and carbonates. As a novel photoelectrochemical catalyst, the performance of the Zeo/Serp (2:1) composite was evaluated for solar hydrogen generation from water splitting relative to its constituents. At −1 V, the Zeo/Serp (2:1) composite produced a maximum current density of 8.44 mA/g versus 7.01, 6.74, and 6.6 mA/g for hydrothermally treated Zeo/Serp (1:1), Zeo, and Serp, respectively. The Zeo/Serp (2:1) photocatalysts had a solar-to-hydrogen conversion efficiency (STH) of 6.5% and an estimated hydrogen output rate of 14.43 mmole/h.g. Consequently, the current research paved the way for low-cost photoelectrochemical catalytic material for efficient solar hydrogen production by water splitting. 相似文献
9.
Fatimah H. Dallak Ibrahim M. Gosadi Wejdan N. Haidar Amjad A. Durayb Abeer R. Alomaish Atheer H. Alshamakhi Raoud M. Khormi Ali H. Almudeer Majed A. Alibrahim 《Medicine》2022,101(41)
This study aimed to measure the prevalence of adverse birth outcomes and associated factors among mothers from the Jazan region in Saudi, Arabia. This was a cross-sectional investigation where data was collected via a semi-structured questionnaire. The questionnaire was completed during interviews to assess data regarding the participants’ demographics, morbidity, the reported adverse birth outcomes, and maternal complications during pregnancy. Chi-squared and Fisher’s Exact tests were both used to compare the distribution of demographic and obstetric risk factors according to the historical presence of adverse birth outcomes. A total of 1315 women with a combined history of 4950 pregnancies were involved in the current investigation. The mean age of the participants was 33.1 years. The total number of adverse birth outcomes was 1009. The most frequently reported adverse birth outcome was miscarriage (12.1%), followed by premature birth (2.3%) and underweight birth (1.9%). Reports of a minimum of 1 adverse birth outcome were higher among women who reported family incomes of more than 10,000 Saudi Arabian Riyal (SAR), women who were first-degree cousins of their husbands, and women with less than a secondary level education (P values <.05). This study found a relatively high prevalence of miscarriage. Further investigations are needed to assess factors associated with this high frequency level of miscarriage. Furthermore, these findings have preventive and clinical implications concerning pregnant women with a history of obesity, anemia, consanguinity, and hypertension. The goal is to target them with a better range of antenatal care services to reduce the incidence of potential adverse birth outcomes. 相似文献
10.